Medtech companies try to head off price increases after tariffs:
Medtech companies such as Boston Scientific, GE HealthCare and Baxter are taking measures to ...
modernhealthcare.com/digital-health/tariffs-cardinal-health-intuitive-surgical-baxter
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
Similar to This
Previous
Paid articlePaywall What a competitive robotic surgery market means for providers
modernhealthcare.com/medical-devices/mh-jj-ottava-robotic-surgery-medtronic-intuitive/
J&J enters US robotic surgery market after device gets marketing authorization: Johnson & Johnson said on Wednesday the U.S. Food and Drug Administration had ...
finance.yahoo.com/healthcare/articles/j-j-enters-us-robotic-112150242.html
Silicon Valley medtech giant halts H-1B hiring – Visa uncertainty puts thousands of jobs at risk
financialexpress.com/world-news/us-news/silicon-valley-medtech-giant-halts-h-1b-hiring-visa-uncertainty-puts-thousands-of-jobs-at-risk/3991080/
Intuitive Surgical collapses - | this is the reason: Intuitive Surgical shares fall after CFO warns about rising tariffs and possible price increases.
deraktionaer.de/artikel/medien-ittk-technologie/intuitive-surgical-bricht-ein-das-ist-der-grund-20385921.html
Paid articlePaywall Intuitive Surgical under pressure: Is the moat in danger?: Deutsche Bank downgrades Intuitive Surgical from "Hold" to "Sell," price target drops from $515 to ...
deraktionaer.de/artikel/medien-ittk-technologie/intuitive-surgical-unter-druck-ist-der-burggraben-in-gefahr-20381525.html
Minnesota medtech firms increase lobbying as tariff costs pile up : Medtronic, Abbott Laboratories and Boston Scientific, which have large Minnesota workforces ...
startribune.com/medtech-lobbying/601366363
Lilly Leads S&P Health With 1,241% Gain. But Its Peers Aren't Slackers.: Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health ...
investors.com/news/technology/sp-500-eli-lilly-health-care-stocks/
What Investors Should Know About the $26 Billion Opioid Settlement : We review potential impact on valuation for the four companies involved.
morningstar.com/articles/1057262/what-investors-should-know-about-the-26-billion-opioid-settlement
Drug companies seek billion-dollar tax deductions from opioid settlement: Four companies that agreed to pay a combined $26 billion to settle claims about their ...
washingtonpost.com/business/2021/02/12/opioid-settlement-tax-refund/
Next